REFERENCES
1. Echevarría ME, Fangusaro J, Goldman S. Pediatric central nervous system germ cell tumors: a review. Oncologist.2008;13(6):690-699.
2. Gamis AS. Acute myeloid leukemia and Down syndrome evolution of modern therapy–state of the art review. Pediatr Blood Cancer.2005;44(1):13-20.
3. Satgé D, Sommelet D, Geneix A, Nishi M, Malet P, Vekemans M. A tumor profile in Down syndrome. Am J Med Genet. 1998;78(3):207-216.
4. Sadakata E, Yoshida K, Baba S, Fuku K, Matsuo T. A case of basal ganglia germ cell tumor associated with Down’s syndrome. In: Nervous System in Children; 2021.
5. Lehrnbecher T, Varwig D, Kaiser J, Reinhardt D, Klingebiel T, Creutzig U. Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial AML-BFM 93. Leukemia. 2004;18(1):72-77.
6. Ullrich NJ, Robertson R, Kinnamon DD, et al. Moyamoya following cranial irradiation for primary brain tumors in children.Neurology. 2007;68(12):932-938.
7. Hassler A, Bochennek K, Gilfert J, et al. Infectious Complications in Children With Acute Myeloid Leukemia and Down Syndrome: Analysis of the Prospective Multicenter Trial AML-BFM 2004. Pediatr Blood Cancer.2016;63(6):1070-1074.
8. Maeda Y, Yoshikawa K, Kajiwara K, et al. Intracranial yolk sac tumor in a patient with Down syndrome. J Neurosurg Pediatr.2011;7(6):604-608.
9. Komiya K, Iwamoto H, Misugi K. A case of cerebellar tumor associated with Down’s syndrome. Congenital Anomalies. 1975;15:212-213.
10. Nakato H, Kuwabara S, Maesako N, et al. [A case of Down’s syndrome complicated by teratoma of the third ventricle of the brain (author’s transl)]. No To Shinkei. 1982;34(2):145-150.
11. Yamasaki S, Hamasaki Y. A infant case of brain tumor associated with Down’s syndrome (in Japanese). In. Vol 54. Arch Jpn Chir1985:305.
12. Fujita T, Yamada K, Saitoh H, Itoh S, Nakai O. Intracranial germinoma and Down’s syndrome–case report. Neurol Med Chir (Tokyo). 1992;32(3):163-165.
13. Oshita N, Yamashita K, Gotou K, Nagata I, Ueda H, Mitani T. [A case of endodermal sinus tumor in the basal ganglia associated with Down’s syndrome]. No Shinkei Geka. 1993;21(4):345-349.
14. Wada H, Kubo M, Wada T, et al. [A case report of a 6-year-old boy with intracranial yolk sac tumor treated by VAB-6 regimen]. No Shinkei Geka. 1995;23(1):65-68.
15. Nakashima T, Nishimura Y, Sakai N, Yamada H, Hara A. Germinoma in cerebral hemisphere associated with Down syndrome. Childs Nerv Syst. 1997;13(10):563-566.
16. Hokezu Y, Okada A, Kanehisa Y, Nagamatsu K, Matsunaga M. Down syndrome associated with radiosensitive brain tumor. Shenkei Naika. 1987;26(8):3.
17. Tanabe M, Mizushima M, Anno Y, et al. Intracranial germinoma with Down’s syndrome: a case report and review of the literature. Surg Neurol. 1997;47(1):28-31.
18. Matsumura N, Kurimoto M, Endo S, Fukuda O, Takaku A. Intracranial germinoma associated with Down’s syndrome. Report of 2 cases.Pediatr Neurosurg. 1998;29(4):199-202.
19. Chik K, Li C, Shing MM, Leung T, Yuen PM. Intracranial germ cell tumors in children with and without Down syndrome. J Pediatr Hematol Oncol. 1999;21(2):149-151.
20. Tan HW, Ty A, Goh SG, Wong MC, Hong A, Chuah KL. Pineal yolk sac tumour with a solid pattern: a case report in a Chinese adult man with Down’s syndrome. J Clin Pathol. 2004;57(8):882-884.
21. Satoh S, Goto H, Izaki K, Sakuma H, Watanabe K. [Intracranial germinoma associated with Down syndrome: case report and review of literature]. No Shinkei Geka. 2012;40(2):137-143.
22. Sugimoto K, Ideguchi M, Sadahiro H, et al. Yolk sac tumor of the bilateral basal ganglia in a patient with Down syndrome. Brain Tumor Pathol. 2013;30(4):247-252.
23. Bakhtiar Y, Yonezawa H, Bohara M, et al. Posterior fossa immature teratoma in an infant with trisomy 21: A case report and review of the literature. Surg Neurol Int. 2012;3:100.
24. Robson CD, Price DL, Barnes PD, Taylor GA. Radiologic-pathologic conference of Children’s Hospital Boston: pineal region mass in a neonate. Pediatr Radiol. 1997;27(10):829-831.
25. Hashimoto T, Sasagawa I, Ishigooka M, et al. Down’s syndrome associated with intracranial germinoma and testicular embryonal carcinoma. Urol Int. 1995;55(2):120-122.
26. Nodomi S, Umeda K, Ueno H, et al. Efficacy of Ifosfamide-Cisplatin-Etoposide (ICE) Chemotherapy for a CNS Germinoma in a Child With Down Syndrome. J Pediatr Hematol Oncol.2017;39(1):e39-e42.
27. Endo S, Kobayashi H, Terasaka S, et al. Primary intracranial yolk sac tumor in the posterior fossa: case report of a child with Down syndrome. Clin Neurol Neurosurg. 2013;115(6):811-813.
28. Abu Arja MH, Conley SE, Salceda V, Al-Sufiani F, Boué DR, Finlay JL. Brentuximab-vedotin maintenance following chemotherapy without irradiation for primary intracranial embryonal carcinoma in down syndrome. Childs Nerv Syst. 2018;34(4):777-780.
29. Miyake Y, Adachi JI, Suzuki T, Mishima K, Sasaki A, Nishikawa R. Craniospinal Germinomas in Patient with Down Syndrome Successfully Treated with Standard-Dose Chemotherapy and Craniospinal Irradiation: Case Report and Literature Review. World Neurosurg.2017;108:995.e999-995.e915.
30. Tempaku A. Basal Ganglia Germinoma Associated with Down Syndrome in a Female Patient. BAOJ Neurol. 2018;4:50.
31. Takada A, Ii N, Hirayama M, et al. Long-term follow-up of intensive chemotherapy followed by reduced-dose and reduced-field irradiation for intracranial germ cell tumor. J Neurosurg Pediatr.2018;23(3):317-324.
32. Dagri J, Torkildson J, Cheng J, et al. GC-08 CENTRAL NERVOUS SYSTEM (CNS) GERM CELL TUMORS (GCT) AND DOWN SYNDROME: TREATMENT STRATEGIES AND MORBIDITIES. In. Neuro Oncology (supplement)2012.
33. Kaatsch P, Rickert CH, Kühl J, Schüz J, Michaelis J. Population-based epidemiologic data on brain tumors in German children.Cancer. 2001;92(12):3155-3164.
34. Keene D, Johnston D, Strother D, et al. Epidemiological survey of central nervous system germ cell tumors in Canadian children. J Neurooncol. 2007;82(3):289-295.
35. Ostrom QT, de Blank PM, Kruchko C, et al. Alex’s Lemonade Stand Foundation Infant and Childhood Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011. Neuro Oncol.2015;16 Suppl 10:x1-x36.
36. Zhou D, Zhang Y, Liu H, Luo S, Luo L, Dai K. Epidemiology of nervous system tumors in children: a survey of 1,485 cases in Beijing Tiantan Hospital from 2001 to 2005. Pediatr Neurosurg. 2008;44(2):97-103.
37. Shibui S. Report of brain tumor registry of Japan (2001–2004).Neurologia medico-chirurgica. 2014;54(suppl. 1).
38. Poynter JN, Fonstad R, Tolar J, Spector LG, Ross JA. Incidence of intracranial germ cell tumors by race in the United States, 1992-2010.J Neurooncol. 2014;120(2):381-388.
39. Kakkar A, Biswas A, Kalyani N, et al. Intracranial germ cell tumors: a multi-institutional experience from three tertiary care centers in India. Childs Nerv Syst. 2016;32(11):2173-2180.
40. Sano K. Pathogenesis of intracranial germ cell tumors reconsidered.J Neurosurg. 1999;90(2):258-264.
41. Wang M, Zhou P, Zhang S, et al. Clinical features, radiologic findings, and treatment of pediatric germ cell tumors involving the basal ganglia and thalamus: a retrospective series of 15 cases at a single center. Childs Nerv Syst. 2018;34(3):423-430.
42. Crawford JR, Santi MR, Vezina G, et al. CNS germ cell tumor (CNSGCT) of childhood: presentation and delayed diagnosis. Neurology.2007;68(20):1668-1673.
43. Kyritsis AP. Management of primary intracranial germ cell tumors.J Neurooncol. 2010;96(2):143-149.
44. Bartels U, Onar-Thomas A, Patel SK, et al. Phase II Trial of Response-Based Radiation Therapy for Patients with Localized Germinoma: A Children’s Oncology Group Study. Neuro Oncol. 2021.
45. Calaminus G, Bison B, Faure-Conter C, et al. GCT-76. 24Gy WHOLE VENTRICULAR RADIOTHERAPY ALONE IS SUFFICIENT FOR DISEASE CONTROL IN LOCALISED GERMINOMA IN CR AFTER INITIAL CHEMOTHERAPY – EARLY RESULTS OF THE SIOP CNS GCT II STUDY. Neuro-Oncology. 2020;22(Suppl 3):iii343-iii344.
46. Calaminus G, Frappaz D, Kortmann RD, et al. Outcome of patients with intracranial non-germinomatous germ cell tumors-lessons from the SIOP-CNS-GCT-96 trial. Neuro Oncol. 2017;19(12):1661-1672.
47. Goldman S, Bouffet E, Fisher PG, et al. Phase II Trial Assessing the Ability of Neoadjuvant Chemotherapy With or Without Second-Look Surgery to Eliminate Measurable Disease for Nongerminomatous Germ Cell Tumors: A Children’s Oncology Group Study. J Clin Oncol.2015;33(22):2464-2471.
48. Huang X, Zhang R, Zhou LF. Diagnosis and treatment of intracranial immature teratoma. Pediatr Neurosurg. 2009;45(5):354-360.
49. Calaminus G, Kortmann R, Worch J, et al. SIOP CNS GCT 96: final report of outcome of a prospective, multinational nonrandomized trial for children and adults with intracranial germinoma, comparing craniospinal irradiation alone with chemotherapy followed by focal primary site irradiation for patients with localized disease.Neuro Oncol. 2013;15(6):788-796.
50. Goldstein NA, Armfield DR, Kingsley LA, Borland LM, Allen GC, Post JC. Postoperative complications after tonsillectomy and adenoidectomy in children with Down syndrome. Arch Otolaryngol Head Neck Surg.1998;124(2):171-176.
Statements and Declarations : The authors do not have any conflicts of interest to disclose. No funding was used to support this work. The authors have no financial interests to disclose. All authors contributed to the study conception and design. Material preparation, data collection and analysis was performed by Micah K. Harris and Mohamed S. Abdelbaki. The first draft of the manuscript was written by Micah K. Harris, and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Data Sharing: The data that support the findings of this study are available from the corresponding author upon reasonable request.